The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

Pignata, S; Scambia, G; Lorusso, D; De Giorgi, U; Nicoletto, Mo; Lauria, R; Mosconi, Am; Sacco, C; Omarini, C; Tagliaferri, P; Ferrandina, G; Cinieri, S; Savarese, A; Valabrega, G; Pisano, C; Salutari, V; Raspagliesi, F; Kopf, B; Cecere, Sc; Amadio, G; Maltese, G; Di Napoli, M; Greggi, S; Signoriello, S; Daniele, G; Sacco, A; Losito, S; Normanno, N; Perrone, F; Gallo, C; Piccirillo, Mc; Mito, Investigators.